Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study

Figure 2

Comparison with Agilent platform. We conducted a direct comparison with the most recent microarray study which was also carried out on a 60-mer oligonucleotide array but using the Agilent platform [16]. 66% of the genes from Bossers et al. (124 genes out of 288 found in represented on both platforms) were also significantly dysregulated in similar fashion as in our dataset (a) and there was a good concordance based on fold changes over the 124 genes (𝑟²=0.634; 𝑃<0.001; XY pairs =124; b).

(a)

(b)